Samsung Biologics financial statements

삼성바이오로직스KRX:207940 · KOSPI · Healthcare · sector #23
₩1,314,000-2.95%
2026-10-06 close

Samsung Biologics's published financial data is dated 2026-10-04. 2024 revenue was KRW 4.55T. 2024 operating profit was KRW 1.26T.

Reported results

Samsung Biologics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q